🔎 Trials Near Me

Akèy › Maladi kadyovaskilè › Utah › Salt Lake City

Etid klinik pou Maladi kadyovaskilè nan Salt Lake City, UT

14 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan ak bò kote Salt Lake City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)

Ap rekriteFaz 1/2Volontè an sante akeyi
  • University of Utah Health Sciences Center, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07601425

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Olympus Family Medicine, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

Product Surveillance Registry

Ap rekriteEtid obsèvasyon
  • Salt Lake City, Salt Lake City
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Ap rekriteFaz 3
  • Clinical Trial Site, Salt Lake City
  • Clinical Trial Site, Bountiful · 9 mi lwen
  • Clinical Trial Site, Bountiful · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Ap rekrite
  • University of Utah, Salt Lake City
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Ap rekriteFaz 3
  • The University of Utah, Salt Lake City
  • Progressive Clinical Research, Bountiful · 9 mi lwen
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Ap rekriteFaz 4Volontè an sante akeyi
  • VA Salt Lake City Healthcare System, Salt Lake City
Laj 75 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT04262206

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Ap rekriteFaz 3
  • Research Site, Bountiful · 9 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Global Paradise System US Post Approval Study

Ap rekriteEtid obsèvasyon
  • St. Mark's Hospital, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06297291

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

Ap rekriteFaz 3
  • Primary Childrens Medical Center, Salt Lake City
Laj 2 a 11 · Tout sèks · Mizajou Jul 24, 2026 · NCT06597006

Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy

Ap rekriteVolontè an sante akeyi
  • University of Utah Hospital, Salt Lake City
Laj 18 ak plis · Fanm · Mizajou Jun 23, 2026 · NCT05826925

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Ap rekrite
  • University of Utah Hospital, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195

Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

Ap rekriteFaz 3
  • Primary Childrens Medical Center, Salt Lake City
  • Primary Childrens Medical Center, Salt Lake City
Laj 6 a 11 · Tout sèks · Mizajou May 15, 2026 · NCT06597019

Randomized Trial of SGLT2i in Heart Transplant Recipients

Ap rekriteFaz 4
  • VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Jan 22, 2026 · NCT06625073

Etid Maladi kadyovaskilè nan lòt vil

Lòt etid nan Salt Lake City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.